Recognizing depression as an inflammatory disease: the search for endotypes.

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Major Depressive Disorder (MDD) affects millions globally, posing significant socioeconomic burdens.
• Treatment resistance is common in MDD, often linked to elevated proinflammatory cytokines and immune activation.
• A subset of MDD patients exhibits inflammatory endotypes, necessitating personalized therapeutic strategies.

Purpose of the Study:

• To explore the intricate relationship between inflammation and depression.
• To elucidate how inflammatory signals contribute to depressive symptoms.
• To highlight immune-modulating therapeutic strategies for inflammatory depression.

Main Methods:

• Review of existing literature on inflammation, MDD, and the gut microbiome.
• Analysis of the role of proinflammatory cytokines in MDD pathophysiology.
• Examination of the gut-brain axis and immune cell communication.

Main Results:

• Inflammation plays a key role in MDD, with distinct inflammatory and non-inflammatory endotypes identified.
• The gut microbiome influences mental health via immune pathways, including short-chain fatty acids (SCFAs).
• Bidirectional communication between the CNS and peripheral immune system is crucial in depression.

Conclusions:

• Identifying distinct inflammatory endotypes is vital for tailoring effective depression treatments.
• Targeting inflammation and the gut microbiome presents promising therapeutic avenues.
• Vagus nerve stimulation may be beneficial for inflammatory depression endotypes.